Lung cancer tumor testing—sometimes referred to as molecular, biomarker or genomic testing—looks for changes (mutations) in the tumor's DNA.
Need help? Contact our lung health specialists at the Lung HelpLine 1-800-LUNGUSA (1-800-586-4872).
Generous support for the My Lung Cancer Treatment Planning Tool made possible by Lilly Oncology.
Lung cancer tumor testing —sometimes referred to as molecular, biomarker or genomic testing— looks for changes (mutations) in the tumor's DNA. Some lung cancer treatments can "target" these mutations directly. This type of testing can also look for levels of certain proteins in your tumor, like PD-L1, which provides key information about how you might respond to immunotherapy.
Ask your doctor about comprehensive genomic testing. This looks for a large number of mutations and proteins in all the genes known to be associated with lung cancer.
Learn more at Lung.org/tumor-testing